192 related articles for article (PubMed ID: 33956062)
1. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Goepfert RP; Duvall A; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Shete S
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):615-623. PubMed ID: 33956062
[TBL] [Abstract][Full Text] [Related]
2. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
[TBL] [Abstract][Full Text] [Related]
3. Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Lu C; Goepfert RP; Fuller CD; Lai SY; Gunn GB; Chambers MS; Sturgis EM; Hanna EY; Shete S
Cancer; 2021 Dec; 127(23):4470-4480. PubMed ID: 34358341
[TBL] [Abstract][Full Text] [Related]
4. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Lai SY; Fuller CD; Lewin JS; Piller LB; Hutcheson KA
Head Neck; 2019 Nov; 41(11):3880-3894. PubMed ID: 31441572
[TBL] [Abstract][Full Text] [Related]
5. Self-reported oral morbidities in long-term oropharyngeal cancer survivors: A cross-sectional survey of 906 survivors.
MD Anderson Head and Neck Cancer Symptom Working Group
Oral Oncol; 2018 Sep; 84():88-94. PubMed ID: 30115482
[TBL] [Abstract][Full Text] [Related]
6. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
[TBL] [Abstract][Full Text] [Related]
7. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors.
Aggarwal P; Goepfert RP; Garden AS; Garg N; Zaveri JS; Du XL; Swartz MD; Lai SY; Fuller CD; Ferrarotto R; Sturgis EM; Piller LB; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2021 May; 147(5):469-478. PubMed ID: 33538759
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.
Aggarwal P; Hutcheson KA; Goepfert RP; Garden AS; Garg N; Mott FE; Fuller CD; Lai SY; Gunn GB; Chambers MS; Hanna EY; Sturgis EM; Shete S
Head Neck; 2022 Apr; 44(4):952-963. PubMed ID: 35084077
[TBL] [Abstract][Full Text] [Related]
9. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
; Eraj SA; Jomaa MK; Rock CD; Mohamed ASR; Smith BD; Smith JB; Browne T; Cooksey LC; Williams B; Temple B; Preston KE; Aymard JM; Gross ND; Weber RS; Hessel AC; Ferrarotto R; Phan J; Sturgis EM; Hanna EY; Frank SJ; Morrison WH; Goepfert RP; Lai SY; Rosenthal DI; Mendoza TR; Cleeland CS; Hutcheson KA; Fuller CD; Garden AS; Gunn GB
Radiat Oncol; 2017 Sep; 12(1):150. PubMed ID: 28888224
[TBL] [Abstract][Full Text] [Related]
10. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
[TBL] [Abstract][Full Text] [Related]
11. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer.
Dohopolski MJ; Diao K; Hutcheson KA; Akhave NS; Goepfert RP; He W; Lei XJ; Peterson SK; Shen Y; Sumer BD; Smith BD; Sher DJ
JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):697-707. PubMed ID: 37382943
[TBL] [Abstract][Full Text] [Related]
12. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors.
Aggarwal P; Nader ME; Gidley PW; Pratihar R; Jivani S; Garden AS; Mott FE; Goepfert RP; Ogboe CW; Charles C; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Hutcheson KA; Shete S
Cancer Med; 2023 Jan; 12(1):569-583. PubMed ID: 35695117
[TBL] [Abstract][Full Text] [Related]
13. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
[TBL] [Abstract][Full Text] [Related]
14. Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.
Ward MC; Ross RB; Koyfman SA; Lorenz R; Lamarre ED; Scharpf J; Burkey BB; Joshi NP; Woody NM; Prendes B; Houston N; Reddy CA; Greskovich JF; Adelstein DJ
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1164-1170. PubMed ID: 27438230
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors.
Diao K; Lei X; Smith GL; Jagsi R; Peterson SE; Sumer BD; Smith BD; Sher DJ
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):142-153. PubMed ID: 36812043
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study.
Vainshtein JM; Griffith KA; Feng FY; Vineberg KA; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):973-980. PubMed ID: 24803039
[TBL] [Abstract][Full Text] [Related]
17. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors.
Goepfert RP; Fuller CD; Gunn GB; Hanna EY; Lewin JS; Zaveri JS; Hubbard RM; Barrow MP; Hutcheson KA
Head Neck; 2017 Nov; 39(11):2151-2158. PubMed ID: 28736965
[TBL] [Abstract][Full Text] [Related]
18. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
[TBL] [Abstract][Full Text] [Related]
19. Return to Work in Survivors of Human Papillomavirus-Associated Oropharyngeal Cancer: An Australian Experience.
Morales CZ; McDowell L; Lisy K; Piper A; Jefford M
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):146-156. PubMed ID: 31521718
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.
Orlandi E; Miceli R; Infante G; Mirabile A; Alterio D; Cossu Rocca M; Denaro N; Vigna-Taglianti R; Merlotti A; Schindler A; Pizzorni N; Fallai C; Licitra L; Bossi P
Dysphagia; 2019 Feb; 34(1):52-62. PubMed ID: 29948260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
